Search Results - "fanale, M"

The ECHELON-2 Trial: 5-year results of a randomized, phase III study of brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma by Horwitz, S., O'Connor, O.A., Pro, B., Trümper, L., Iyer, S., Advani, R., Bartlett, N.L., Christensen, J.H., Morschhauser, F., Domingo-Domenech, E., Rossi, G., Kim, W.S., Feldman, T., Menne, T., Belada, D., Illés, Á., Tobinai, K., Tsukasaki, K., Yeh, S.-P., Shustov, A., Hüttmann, A., Savage, K.J., Yuen, S., Zinzani, P.L., Miao, H., Bunn, V., Fenton, K., Fanale, M., Puhlmann, M., Illidge, T.

“…For patients with peripheral T-cell lymphoma (PTCL), outcomes using frontline treatment with cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP)…”
Get full text

Rapid Evolution of the Gaseous Exoplanetary Debris around the White Dwarf Star HE 1349-2305 by Dennihy, E., Clemens, J. C., Dunlap, B. H., Fanale, S. M., Fuchs, J. T., Hermes, J. J.

“…Observations of heavy metal pollution in white dwarf stars indicate that metal-rich planetesimals are frequently scattered into star-grazing orbits, tidally…”
Get full text

Oral lenalidomide with rituximab in relapsed or refractory diffuse large cell, follicular and transformed lymphoma: a phase II clinical trial by Wang, M, Fowler, N, Wagner-Bartak, N, Feng, L, Romaguera, J, Neelapu, S S, Hagemeister, F, Fanale, M, Oki, Y, Pro, B, Shah, J, Thomas, S, Younes, A, Hosing, C, Zhang, L, Newberry, K J, Desai, M, Cheng, N, Badillo, M, Bejarano, M, Chen, Y, Young, K H, Champlin, R, Kwak, L, Fayad, L

“…Lenalidomide–rituximab therapy is effective in grade 1–2 follicular and mantle cell lymphoma, but its efficacy in diffuse large B-cell lymphoma (DLBCL),…”
Get full text

Allogeneic stem-cell transplantation in patients with cutaneous lymphoma: updated results from a single institution by Hosing, C., Bassett, R., Dabaja, B., Talpur, R., Alousi, A., Ciurea, S., Popat, U., Qazilbash, M., Shpall, E.J., Oki, Y., Nieto, Y., Pinnix, C., Fanale, M., Maadani, F., Donato, M., Champlin, R., Duvic, M.

“…Cutaneous T-cell lymphomas (CTCLs) and its common variants mycosis fungoides (MF) and leukemic Sézary syndrome (SS) are rare extranodal non-Hodgkin's…”
Get full text

Phase II study of idelalisib, a selective inhibitor of PI3Kδ, for relapsed/refractory classical Hodgkin lymphoma by Gopal, A.K., Fanale, M.A., Moskowitz, C.H., Shustov, A.R., Mitra, S., Ye, W., Younes, A., Moskowitz, A.J.

“…The phosphatidylinositol-3-kinase delta (PI3Kδ) inhibitor idelalisib has been shown to block downstream intracellular signaling, reduce the production of…”
Get full text

A randomized trial of a single-dose rasburicase versus five-daily doses in patients at risk for tumor lysis syndrome by Vadhan-Raj, S., Fayad, L.E., Fanale, M.A., Pro, B., Rodriguez, A., Hagemeister, F.B., Bueso-Ramos, C.E., Zhou, X., McLaughlin, P.W., Fowler, N., Shah, J., Orlowski, R.Z., Samaniego, F., Wang, M., Cortes, J.E., Younes, A., Kwak, L.W., Sarlis, N.J., Romaguera, J.E.

“…Tumor lysis syndrome (TLS) is a life-threatening disorder characterized by hyperuricemia and metabolic derangements. The efficacy of rasburicase, administered…”
Get full text

Efficacy and safety of antiretrovirals in HIV-infected patients with cancer by Torres, H.A., Rallapalli, V., Saxena, A., Granwehr, B.P., Viola, G.M., Ariza-Heredia, E., Adachi, J.A., Chemaly, R.F., Marfatia, R., Jiang, Y., Mahale, P., Kyvernitakis, A., Fanale, M.A., Mulanovich, V.

“…At 30 years into the HIV infection epidemic, the optimal antiretroviral (ARV) regimen for infected patients with cancer remains unknown. We therefore sought to…”
Get full text

Patients with classical Hodgkin lymphoma experiencing disease progression after treatment with brentuximab vedotin have poor outcomes by Cheah, C.Y., Chihara, D., Horowitz, S., Sevin, A., Oki, Y., Zhou, S., Fowler, N.H., Romaguera, J.E., Turturro, F., Hagemeister, F.B., Fayad, L.E., Wang, M., Neelapu, S.S., Nastoupil, L.J., Westin, J.R., Rodriguez, M.A., Samaniego, F., Anderlini, P., Nieto, Y., Fanale, M.A.

“…Brentuximab vedotin (BV) is a key therapeutic agent for patients with relapsed/refractory classical Hodgkin lymphoma (cHL). The outcomes of patients…”
Get full text

Factors influencing outcome in advanced stage, low-grade follicular lymphoma treated at MD Anderson Cancer Center in the rituximab era by Cheah, C.Y., Chihara, D., Ahmed, M., Davis, R.E., Nastoupil, L.J., Phansalkar, K., Hagemeister, F.B., Fayad, L.E., Westin, J.R., Oki, Y., Fanale, M.A., Romaguera, J.E., Wang, M.L., Lee, H., Turturro, F., Samaniego, F., Rodriguez, M.A., Neelapu, S.S., Fowler, N.H.

“…The optimal initial therapy of follicular lymphoma (FL) remains unclear. The aims of this study were to compare primary treatment strategies and assess the…”
Get full text

BRENTUXIMAB VEDOTIN WITH CHEMOTHERAPY IN ADOLESCENTS AND YOUNG ADULTS (AYAS) WITH STAGE III OR IV HODGKIN LYMPHOMA: A SUBGROUP ANALYSIS FROM THE PHASE 3 ECHELON‐1 STUDY by Crosswell, H. E, LaCasce, A. S., Bartlett, N. L, Straus, D. J, Savage, K. J, Zinzani, P. L, Collins, G. P, Fanale, M. A, Fenton, K, Dong, C, Miao, H. H, Grigg, A. P

Get full text

NIVOLUMAB PLUS BRENTUXIMAB VEDOTIN FOR RELAPSED/REFRACTORY PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA: EXTENDED FOLLOW‐UP FROM THE PHASE 2 CHECKMATE 436 STUDY by Zinzani, P. L., Santoro, A., Gritti, G., Brice, P., Barr, P. M., Kuruvilla, J., Cunningham, D., Kline, J., Johnson, N. A., Mehta‐Shah, N., Fanale, M., Francis, S., Moskowitz, A. J.

Get full text

Postchemotherapy Positron Emission Tomography/Computed Tomography Scans in Early-Stage Hodgkin Lymphoma: Moving Beyond the Deauville 5-Point Scale by Milgrom, S.A, Dong, W, Akhtari, M, Smith, G.L, Pinnix, C.C, Mawlawi, O.R, Rohren, E.M, Garg, N, Chuang, H.H, Yehia, Z. Abou, Reddy, J, Gunther, J.R, Osborne, E.M, Oki, Y, Fanale, M, Dabaja, B

Get full text

More Chemotherapy Does Not Obviate the Need for Radiation Therapy (RT): Treatment for Early-Stage Favorable Hodgkin Lymphoma According to the HD10 Trial Compared With Chemotherapy Alone by Pinnix, C.C, Abou Yehia, Z, Smith, G.L, Milgrom, S.A, Ho, J.C, Reddy, J, Gunther, J.R, Akhtari, M, Osborne, E.M, Medeiros, L.J, Fanale, M, Dabaja, B

Get full text

Pretreatment Neutrophil/Lymphocyte Ratio Predicts Relapse in Stage I and II Hodgkin Lymphoma by Reddy, J, Gunther, J.R, Dabaja, B, Akhtari, M, Martin, G.V, Allen, P.K, Aktinson, B.J, Smith, G.L, Pinnix, C.C, Milgrom, S.A, Yehia, Z. Abou, Osborne, E.M, Fanale, M

Get full text

Treatment of Early-Stage Unfavorable Hodgkin Lymphoma: Efficacy and Toxicity of 4 Versus 6 Cycles of ABVD Chemotherapy With Radiation by Gunther, J.R, Fanale, M, Reddy, J, Akhtari, M, Smith, G.L, Pinnix, C.C, Milgrom, S.A, Yehia, Z. Abou, Osborne, E.M, Mawlawi, O.R, Allen, P.K, Dabaja, B

Get full text

Restratifying Early-Stage Hodgkin Lymphoma Patients Using Novel Functional Imaging Parameters by Akhtari, M, Reddy, J, Dong, W, Milgrom, S.A, Smith, G.L, Pinnix, C.C, Yehia, Z. Abou, Gunther, J.R, Osborne, E.M, Mawlawi, O.R, Rohren, E.M, Chuang, H.H, Garg, N, Fanale, M, Dabaja, B

Get full text

Prognostic Significance of the Postchemotherapy Positron Emission Tomography (PET)/Computed Tomography in Early-Stage Hodgkin Lymphoma: Can PET-Positive Patients Be Cured With Radiation Alone? by Milgrom, S.A, Smith, G.L, Pinnix, C.C, Dong, W, Akhtari, M, Mawlawi, O.R, Rohren, E.M, Garg, N, Chuang, H.H, Reddy, J, Gunther, J.R, Osborne, E.M, Yehia, Z. Abou, Oki, Y, Fanale, M, Dabaja, B

Get full text

Comprehensive genomic profiling reveals recurrent XPO1 mutations and other alterations in archival samples of patients with Hodgkin lymphoma by Janku, F, Vergilio, J.A, Salhia, B, Fanale, M, Oki, Y, Huang, H, Westin, J, He, J, Nahas, M, Mughal, T, Miller, V, Stephens, P, Raina, A, Garrido-Laguna, I, Meric-Bernstam, F, Ross, J, Liang, W

“…An abstract of the study of Janku et al. about recurrent XPOI mutations and other alterations in archival samples of patients with Hodgkin lymphoma is…”
Get full text

RESPONSE TO BRENTUXIMAB VEDOTIN BY CD30 EXPRESSION: RESULTS FROM FIVE TRIALS IN PTCL, CTCL, AND B‐CELL LYMPHOMAS by Jagadeesh, D., Horwitz, S., Bartlett, N.L., Advani, R., Jacobsen, E., Duvic, M., Gautman, A., Rao, S., Onsum, M., Fanale, M., Kim, Y.

Get full text

Outcomes After Chemotherapy Followed by Radiation for Stage IIB Hodgkin Lymphoma With Bulky Disease by Reddy, J, Akhtari, M, Smith, G.L, Pinnix, C.C, Osborne, E.M, Gunther, J.R, Allen, P.K, Fanale, M, Rodriguez, M.A, Fowler, N, Milgrom, S.A, Wogan, C.F, Dabaja, B

Get full text